Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (03ZZ0819A, 03ZZ0819C, 03ZZ0819D, 03ZZ0819B)
Text and Data Mining valid from 2018-07-16
Received: 8 December 2017
Accepted: 3 July 2018
First Online: 16 July 2018
Ethics approval and consent to participate
: Ethical approval was obtained from University of Erfurt’s IRB and can be accessed via the open science repository [ CitationRef removed ]. Informed written consent will be collected from the study participants where participants are involved. Informed consent will be collected and saved at the respective centers.
: Not applicable.
: CB, CR, HCV, AF, OW, DH, PS, SE, WW, AR, NKK, JN, TR, AM, JR, AM: no competing interests.RH, WH, KS: no competing interests. Lindgrün GmbH as commercial entity has no affiliation, business nor connections to the pharmaceutical industry.CFl receives grants from the German Federal Ministry of Education and Research (BMBF) via the Center for Sepsis Control and Care (CSCC; FKZ: 01EO1002 and 01EO1502).CFo and MWP: are partly supported by a grant of the Federal Ministry of Education and Research KliFo 2.0 (grant number 01KI1501).KR receives consulting fees from Adrenomed AG (solution oriented biopharmaceutical company dedicated to drug development treating severe sepsis) and is shareholder at InfalRx (develops new first-in-class therapeutics in the field of acute and chronic inflammation).
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.